Medpace Holdings, Inc. Share Price

Medpace Holdings, Inc. Share Price

NASDAQ: MEDP | Large Cap
$651.99
-$25.30 (-3.74%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Medpace Holdings, Inc. Stock Performance

Open
$670.00
Prev. Close
$677.28
Circuit Range
N/A
Day Range
$648.95 - $670.99
Year Range
$375.00 - $693.69
Volume
13,230
Average Traded
$654.85

Medpace Holdings, Inc. Share Price Today

As of 31 October 2026, Medpace Holdings, Inc.'s share price is $651.99. The stock opened at $670.00, compared to its previous close of $677.28. During today's trading session, Medpace Holdings, Inc.'s share price traded between $648.95 and $670.99, with an average price of $659.97. Over the past 52 weeks, the stock has recorded a high of $693.69 and a low of $375.00. In terms of performance, Medpace Holdings, Inc.'s share price has risen by 55.63% over the last six months and is up 11.56% on a year-on-year basis.

Medpace Holdings, Inc. Share Price Chart

Line chart of the Medpace Holdings, Inc. price trend over the selected period. The price fell overall, ranging from 648.69 to 662.84, ending at 651.99.
$648.95$670.99
L
Show Current Price
H

Medpace Holdings, Inc. Stock Fundamentals & Key Indicators

Market Cap
$18.81B
PE Ratio (TTM)
35.22
Dividend Yield
0.00%
EPS (TTM)
$18.51
Revenue (TTM)
$2.53T
Return On Equity (TTM)
88.53%
Profit Margin
17.83%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
1.72%

Medpace Holdings, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$708.45$706.60$707.33$716.00
Net Profit$135.13$123.87$121.36$137.46
Net Profit Margin19.07%17.53%17.16%19.20%
Income ChangeN/A-8.33%-2.03%13.27%

Medpace Holdings, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$1460.00$1885.84$2109.05$2530.23
Net Profit$245.37$282.81$404.39$451.12
Net Profit Margin16.81%15.00%19.17%17.83%
Income ChangeN/A15.26%42.99%11.56%

About Medpace Holdings, Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Medpace Holdings, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$620.81
$652.04
+4.36%
Sep 2026
$593.95
$624.80
+2.18%
Aug 2026
$586.08
$611.45
+5.96%
Jul 2026
$534.87
$577.05
+8.99%
Jun 2026
$447.71
$529.44
+18.36%
May 2026
$421.33
$447.31
+6.77%
Apr 2026
$483.11
$418.94
-12.78%
Mar 2026
$443.33
$480.32
+6.32%
Feb 2026
$578.62
$451.76
-22.40%
Jan 2026
$558.88
$582.16
+3.68%
Dec 2025
$591.91
$561.48
-5.49%
Nov 2025
$581.81
$594.10
+1.65%

MEDP Share Price FAQs